a ligand of signal-regulatory protein-α (SIRPα), and PD-L1, a ligand of programmed cell death protein 1 (PD-1) (Fig. 1). It is now well established that antibodies that block the interaction ...

Adding nivolumab to neoadjuvant chemotherapy significantly improves response rates in high-risk early-stage ER+/HER2− breast ...

Compass Therapeutics, Inc.’s CMPX share price has dipped by 24.55%, which has investors questioning if this is right time to ...

Compass Therapeutics, Inc.’s CMPX share price has surged by 17.89%, which has investors questioning if this is right time to sell.